BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

619 related articles for article (PubMed ID: 29271940)

  • 1. Antiangiogenic Effect of Flavonoids and Chalcones: An Update.
    Mirossay L; Varinská L; Mojžiš J
    Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29271940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiangiogenic effects of flavonoids and chalcones.
    Mojzis J; Varinska L; Mojzisova G; Kostova I; Mirossay L
    Pharmacol Res; 2008 Apr; 57(4):259-65. PubMed ID: 18387817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-angiogenic activity of the flavonoid precursor 4-hydroxychalcone.
    Varinska L; van Wijhe M; Belleri M; Mitola S; Perjesi P; Presta M; Koolwijk P; Ivanova L; Mojzis J
    Eur J Pharmacol; 2012 Sep; 691(1-3):125-33. PubMed ID: 22721615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiangiogenic phytochemicals and medicinal herbs.
    Jeong SJ; Koh W; Lee EO; Lee HJ; Lee HJ; Bae H; Lü J; Kim SH
    Phytother Res; 2011 Jan; 25(1):1-10. PubMed ID: 20564543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of vascular endothelial growth factor (VEGF) and VEGF receptors in tumor angiogenesis and malignancies.
    Pradeep CR; Sunila ES; Kuttan G
    Integr Cancer Ther; 2005 Dec; 4(4):315-21. PubMed ID: 16282508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chalcones against the hallmarks of cancer: a mini-review.
    de Souza PS; Bibá GCC; Melo EDDN; Muzitano MF
    Nat Prod Res; 2022 Sep; 36(18):4809-4826. PubMed ID: 34865580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiangiogenic Activity of Flavonoids: A Systematic Review and Meta-Analysis.
    Khater M; Greco F; Osborn HMI
    Molecules; 2020 Oct; 25(20):. PubMed ID: 33066630
    [No Abstract]   [Full Text] [Related]  

  • 8. Targeting Angiogenesis in Cancer Therapy: Moving Beyond Vascular Endothelial Growth Factor.
    Zhao Y; Adjei AA
    Oncologist; 2015 Jun; 20(6):660-73. PubMed ID: 26001391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiangiogenesis beyond VEGF inhibition: a journey from antiangiogenic single-target to broad-spectrum agents.
    Limaverde-Sousa G; Sternberg C; Ferreira CG
    Cancer Treat Rev; 2014 May; 40(4):548-57. PubMed ID: 24360358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting vasculogenic mimicry by phytochemicals: A potential opportunity for cancer therapy.
    Haiaty S; Rashidi MR; Akbarzadeh M; Maroufi NF; Yousefi B; Nouri M
    IUBMB Life; 2020 May; 72(5):825-841. PubMed ID: 32026601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiogenesis as a potential target of pharmaconutrients in cancer therapy.
    Granci V; Dupertuis YM; Pichard C
    Curr Opin Clin Nutr Metab Care; 2010 Jul; 13(4):417-22. PubMed ID: 20453647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Target inhibition in antiangiogenic therapy a wide spectrum of selectivity and specificity.
    Kelly RJ; Darnell C; Rixe O
    Cancer J; 2010; 16(6):635-42. PubMed ID: 21131797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of Chalcones from Medicago sativa L. and Their Hypolipidemic and Antiangiogenic Activities.
    Ma QG; Li T; Wei RR; Liu WM; Sang ZP; Song ZW
    J Agric Food Chem; 2016 Nov; 64(43):8138-8145. PubMed ID: 27741571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiangiogenic therapy and tumor progression.
    Blagosklonny MV
    Cancer Cell; 2004 Jan; 5(1):13-7. PubMed ID: 14749122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoxia inducible factor-1 independent pathways in tumor angiogenesis.
    Mizukami Y; Kohgo Y; Chung DC
    Clin Cancer Res; 2007 Oct; 13(19):5670-4. PubMed ID: 17908955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [VEGF in neoplastic angiogenesis].
    Chekhonin VP; Shein SA; Korchagina AA; Gurina OI
    Vestn Ross Akad Med Nauk; 2012; (2):23-33. PubMed ID: 22642175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of Hypoxia-inducible Factor-1α and Vascular Endothelial Growth Factor Signaling by Plant Flavonoids.
    Fernando W; Rupasinghe HP; Hoskin DW
    Mini Rev Med Chem; 2015; 15(6):479-89. PubMed ID: 25873069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The VEGF/Rho GTPase signalling pathway: a promising target for anti-angiogenic/anti-invasion therapy.
    van der Meel R; Symons MH; Kudernatsch R; Kok RJ; Schiffelers RM; Storm G; Gallagher WM; Byrne AT
    Drug Discov Today; 2011 Mar; 16(5-6):219-28. PubMed ID: 21262381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiogenesis in spontaneous tumors and implications for comparative tumor biology.
    Benazzi C; Al-Dissi A; Chau CH; Figg WD; Sarli G; de Oliveira JT; Gärtner F
    ScientificWorldJournal; 2014; 2014():919570. PubMed ID: 24563633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Angiogenesis and antiangiogenic cancer therapy].
    Pour L; Hájek R; Buchler T; Maisnar V; Smolej L
    Vnitr Lek; 2004 Dec; 50(12):930-8. PubMed ID: 15717808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.